Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis
This analysis aims to compare the cardiovascular outcomes of drug-coated balloons and drug-eluting stents in treating peripheral arterial disease.
Conducted a meta-regression analysis of existing studies
Compared outcomes of drug-coated balloons and drug-eluting stents
Assessed all-cause mortality and primary patency up to 2 years
No significant difference in all-cause mortality between DCB and DES
Primary patency was similar for both treatments up to 2 years
DCB showed lower CD-TLR at 1 year, diminishing by 2 years
Abstract
There was no significant difference in all-cause mortality and primary patency between DCB and DES for up to 2 years. DCB was associated with lower CD-TLR at 1 year, which was lost at 2 years of follow-up.
Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis | Synapse